Patients with one copy of the *9 allele in combination with one copy of the *1A allele may have decreased metabolism of metronidazole as compared to patients with two copies of the *1A allele. Other genetic and clinical factors may also affect metronidazole metabolism. This annotation only covers the pharmacokinetic relationship between CYP2A6 and metronidazole and does not include evidence on clinical outcomes.